Not affiliated: PlexusDx has no commercial relationship with Ro or the maker of Ozempic
If GLP-1 agonists show superior neuroprotective benefits, this could challenge the traditional treatment paradigm and support initiating therapy with GLP-1 agonists in selected patients. GLP-1 agonists have demonstrated mechanisms that include reducing neuroinflammation, enhancing cerebral glucose metabolism, and improving synaptic plasticity, Wu added
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 269,00 per year only 22,42 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
When there is excess growth of these hydrogen sulfide-producing bacteria, it can lead to SIBO and/or dysbiosis, creating issues such as inflammatory bowel disease or irritable bowel syndrome
The decision to advance your dose is individualized and may be informed by genetic testing results through the PlexusDx Precision Peptide Genetic Test
Studies suggest it might lower these male hormones